Serologic response to hepatitis B vaccination in HIV-Infected patients with isolated positivity for antibodies to hepatitis B core antigen

Details

Request a copyRequest a copy
Serval ID
serval:BIB_A0AFEB050ED4
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Production externe
Title
Serologic response to hepatitis B vaccination in HIV-Infected patients with isolated positivity for antibodies to hepatitis B core antigen
Journal
Clin Infect Dis
Author(s)
Chakvetadze C., Bani-Sadr F., Le Pendeven C., Lescure F. X., Fontaine C., Galperine T., Slama L., Bonnard P., Mariot P., Soussan P., Pialoux G.
ISSN
1537-6591 (Electronic)
ISSN-L
1058-4838
Publication state
Published
Issued date
2010
Volume
50
Number
8
Pages
1184-6
Language
english
Notes
Chakvetadze, Catherine
Bani-Sadr, Firouze
Le Pendeven, Catherine
Lescure, Francois-Xavier
Fontaine, Camille
Galperine, Tatiana
Slama, Laurence
Bonnard, Philippe
Mariot, Philippe
Soussan, Patrick
Pialoux, Gilles
eng
2010/03/10
Clin Infect Dis. 2010 Apr 15;50(8):1184-6. doi: 10.1086/651422.
Abstract
We assessed the safety and immunogenicity of hepatitis B vaccination among 40 human immunodeficiency virus-infected patients with isolated positivity for antibodies to hepatitis B core antigen. No baseline factors were found to be predictive of an anamnestic response, which occurred in 32.5% of the patients. The overall response rate among patients without an anamnestic response was 74.0% after 3-6 vaccine doses.
Keywords
Adult, Female, HIV Infections/*immunology, Hepatitis B Antibodies/*blood, Hepatitis B Core Antigens/*immunology, Hepatitis B Vaccines/*adverse effects/*immunology, Humans, Immunologic Memory, Male, Middle Aged
DOI
10.1086/651422
Pubmed
20210647
Create date
30/01/2023 12:16
Last modification date
31/01/2023 7:55
Usage data